Therefore, although VEGF is a potent angiogenic factor associated with pulmonary and chronic inflammatory diseases, our results suggest that it has no influence as a genetic biomarker for the susceptibility of ILD and for the differential diagnosis between the different diseases encompassed under the term ILD. This evidence concerns the gene VEGFA and interstitial lung disease.